Aptorum Group LTD F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
NASDAQ
Aptorum Group Limited is pursuing a strategic merger with DiamiR Biosciences Corp. to enhance its R&D pipeline, despite ongoing financial challenges and a recent capital raise.